These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5306225)

  • 1. [Studies of the hepatotoxicity of triacetyloleandomycin (TAO) in humans].
    Sasso C; Arpino E
    Minerva Med; 1969 May; 60(35):1689-94. PubMed ID: 5306225
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic abnormalities associated with long-term use of troleandomycin in asthma: a case report.
    Dasgupta A; Marcoux JP
    Ann Allergy; 1978 Nov; 41(5):297-8. PubMed ID: 102222
    [No Abstract]   [Full Text] [Related]  

  • 3. Troleandomycin hepatotoxicity: a case report of overt jaundice and a placebo-controlled trial.
    Uzzan B; Vassy R; Nicolas P; Chapman A; Perret G
    Therapie; 1993; 48(1):61-2. PubMed ID: 8356550
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of icterus during treatment with triacetyloleoandomycin as sole therapy].
    Laburthe-Tolra Y
    Sem Hop; 1983 Jun; 59(22):1675-6. PubMed ID: 6308789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on triacetyloleandomycin in the prevention of rheumatic fever: its effects on hepatic function].
    Gilbert G; Tardif B; Lefebvre M; David P
    Laval Med; 1967 Dec; 38(10):911-4. PubMed ID: 5302265
    [No Abstract]   [Full Text] [Related]  

  • 6. Precipitation of acute ergotism by triacetyloleandomycin.
    Hayton AC
    N Z Med J; 1969 Jan; 69(440):42. PubMed ID: 5304704
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A.
    Kostrubsky VE; Szakacs JG; Jeffery EH; Woods SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
    Ann Clin Lab Sci; 1997; 27(1):57-62. PubMed ID: 8997458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ischemia of the extremities caused by a combination of dihydroergotamine and triacetyloleandomycin. New case report].
    Bacourt F; Couffinhal JC
    Nouv Presse Med; 1978 May; 7(18):1561. PubMed ID: 307735
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholestatic jaundice after triacetyloleandomycin and oral contraceptives. The diagnostic value of gamma-glutamyl transpeptidase.
    Haber I; Hubens H
    Acta Gastroenterol Belg; 1980; 43(11-12):475-82. PubMed ID: 6971036
    [No Abstract]   [Full Text] [Related]  

  • 10. [Triacetyloleandomycin-induced toxic hepatitis].
    Shishido H; Furusawa S; Amakawa T; Yamaguchi Y; Nakagawa M
    Naika; 1965 Nov; 16(6):1176-8. PubMed ID: 5296328
    [No Abstract]   [Full Text] [Related]  

  • 11. [Benign drug jaundice during treatment combining rifampicin and triacetyloleandomycin].
    Piette F; Peyrard P
    Nouv Presse Med; 1979 Jan; 8(5):368. PubMed ID: 317969
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Am J Med Sci; 1962 Apr; 243():502-10. PubMed ID: 14492926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association].
    Franco A; Bourlard P; Massot C; Lecoeur J; Guidicelli H; Bessard G
    Nouv Presse Med; 1978 Jan; 7(3):205. PubMed ID: 307229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional disorders of the liver in progressive polyarthritis and their relation to the duration of the disease].
    Vido I; Fecurková R
    Z Rheumaforsch; 1965 Jun; 24(5):197-200. PubMed ID: 5829687
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dihydroergotamine and triacetyloleandomycin combination. Its role in iatrogenic necrosis of the fingers].
    Vayssairat M; Fiessinger JN; Bequemin MH; Housset E
    Nouv Presse Med; 1978 Jun; 7(23):2077. PubMed ID: 307740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Jaundice and hepatic hemangioma after ten years of oral contraception and recent administration of triacetyloleandomycin].
    Meyniel D; Pieron R; Cotillon C; Huguet C; Lecomte D
    Therapie; 1980; 35(6):754-5. PubMed ID: 6972102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma.
    Wald JA; Friedman BF; Farr RS
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):36-43. PubMed ID: 3487564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Crossed hepatotoxicity of erythromycin propionate and troleandomycin?].
    Luherne JY; Pariente EA; Maitre F
    Gastroenterol Clin Biol; 1988 Nov; 12(11):869-70. PubMed ID: 3265396
    [No Abstract]   [Full Text] [Related]  

  • 19. [15. Pathological liver values--alcohol is not always the problem!].
    MMW Fortschr Med; 2001 Jan; 143(4):I-X; quiz XI-XII. PubMed ID: 11219291
    [No Abstract]   [Full Text] [Related]  

  • 20. LIVER FUNCTION STUDIES IN LONG-TERM TRIACETYLOLEANDOMYCIN THERAPY.
    ENGEL MF
    South Med J; 1963 Nov; 56():1279-81. PubMed ID: 14078379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.